Skip to main content
Erschienen in: Journal of Gastroenterology 12/2014

01.12.2014 | Original Article—Alimentary Tract

Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn’s disease

verfasst von: Akira Mukai, Hideki Iijima, Satoshi Hiyama, Hironobu Fujii, Shinichiro Shinzaki, Takahiro Inoue, Eri Shiraishi, Shoichiro Kawai, Manabu Araki, Yoshito Hayashi, Jumpei Kondo, Tsunekazu Mizushima, Tatsuya Kanto, Satoshi Egawa, Tsutomu Nishida, Masahiko Tsujii, Tetsuo Takehara

Erschienen in: Journal of Gastroenterology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Abrogating tolerance is a critical step in the pathogenesis of Crohn’s disease (CD). T cell-anergy is one of the main mechanisms of tolerance and is regulated by the gene related to anergy in lymphocytes (GRAIL). This study investigated the expressions and regulation of GRAIL in CD and murine colitis models.

Methods

Expressions of GRAIL mRNA and protein in CD4+ T cells were investigated in the peripheral blood and mucosal tissues of patients with CD, mice with dextran sodium salt (DSS)-induced colitis, and Il-10-deficient mice. MicroRNAs responsible for the regulation of GRAIL were examined by miRNA microarray. GRAIL-overexpressing T cells were intravenously injected in mice with DSS-induced colitis.

Results

The GRAIL expression was higher in the lamina propria (LP) CD4+ T cells of CD patients than of the control subjects, while it was lower in the peripheral blood CD4+ T cells of the CD patients than of the control subjects. The GRAIL mRNA expression was lower, but the GRAIL protein expression was higher in the LP of colitic mice than that of non-colitic mice. The miRNA microarray identified miR-290-5p as an miRNA that inhibits expression of the GRAIL protein and that is highly expressed in the LP of non-colitic mice. GRAIL-expressing T cells expressed regulatory T cell markers and showed suppressive effects in murine DSS-induced colitis.

Conclusions

Our results show that expression of GRAIL is uniquely regulated by the specific miRNA in the intestinal mucosa, and suggest that GRAIL may associate with the pathophysiology of CD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol. 2013;48:315–21.PubMedCentralPubMedCrossRef Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol. 2013;48:315–21.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Hamilton MJ, Snapper SB, Blumberg RS. Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance. J Gastroenterol. 2012;47:1–8.PubMedCrossRef Hamilton MJ, Snapper SB, Blumberg RS. Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance. J Gastroenterol. 2012;47:1–8.PubMedCrossRef
3.
Zurück zum Zitat Arimura Y, Isshiki H, Onodera K, Nagaishi K, Yamashita K, Sonoda T, et al. Characteristics of Japanese inflammatory bowel disease susceptibility loci. J Gastroenterol. 2013. doi:10.1007/s00535-013-0866-2. Arimura Y, Isshiki H, Onodera K, Nagaishi K, Yamashita K, Sonoda T, et al. Characteristics of Japanese inflammatory bowel disease susceptibility loci. J Gastroenterol. 2013. doi:10.​1007/​s00535-013-0866-2.
4.
Zurück zum Zitat Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390–407.PubMedCrossRef Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390–407.PubMedCrossRef
5.
Zurück zum Zitat Anandasabapathy N, Ford GS, Bloom D, Holness C, Paragas V, Seroogy C, et al. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity. 2003;18:535–47.PubMedCrossRef Anandasabapathy N, Ford GS, Bloom D, Holness C, Paragas V, Seroogy C, et al. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity. 2003;18:535–47.PubMedCrossRef
6.
Zurück zum Zitat Iweala OI, Nagler CR. Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora. Immunol Rev. 2006;213:82–100.PubMedCrossRef Iweala OI, Nagler CR. Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora. Immunol Rev. 2006;213:82–100.PubMedCrossRef
7.
Zurück zum Zitat Kraus TA, Toy L, Chan L, Childs J, Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology. 2004;126:1771–8.PubMedCrossRef Kraus TA, Toy L, Chan L, Childs J, Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology. 2004;126:1771–8.PubMedCrossRef
8.
9.
Zurück zum Zitat Lineberry NB, Su LL, Lin JT, Coffey GP, Seroogy CM, Fathman CG. Cutting edge: the transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. J Immunol. 2008;181:1622–6.PubMedCentralPubMedCrossRef Lineberry NB, Su LL, Lin JT, Coffey GP, Seroogy CM, Fathman CG. Cutting edge: the transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. J Immunol. 2008;181:1622–6.PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Su LL, Iwai H, Lin JT, Fathman CG. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells. J Immunol. 2009;183:438–44.PubMedCrossRef Su LL, Iwai H, Lin JT, Fathman CG. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells. J Immunol. 2009;183:438–44.PubMedCrossRef
11.
Zurück zum Zitat Nurieva RI, Zheng S, Jin W, Chung Y, Zhang Y, Martinez GJ, et al. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity. 2010;32:670–80.PubMedCentralPubMedCrossRef Nurieva RI, Zheng S, Jin W, Chung Y, Zhang Y, Martinez GJ, et al. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity. 2010;32:670–80.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat MacKenzie DA, Schartner J, Lin J, Timmel A, Jennens-Clough M, Fathman CG, et al. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J Biol Chem. 2007;282:9696–702.PubMedCrossRef MacKenzie DA, Schartner J, Lin J, Timmel A, Jennens-Clough M, Fathman CG, et al. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J Biol Chem. 2007;282:9696–702.PubMedCrossRef
13.
Zurück zum Zitat Schartner JM, Singh AM, Dahlberg PE, Nettenstrom L, Seroogy CM. Recurrent superantigen exposure in vivo leads to highly suppressive CD4+ CD25+ and CD4+ CD25− T cells with anergic and suppressive genetic signatures. Clin Exp Immunol. 2009;155:348–56.PubMedCentralPubMedCrossRef Schartner JM, Singh AM, Dahlberg PE, Nettenstrom L, Seroogy CM. Recurrent superantigen exposure in vivo leads to highly suppressive CD4+ CD25+ and CD4+ CD25 T cells with anergic and suppressive genetic signatures. Clin Exp Immunol. 2009;155:348–56.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Egawa S, Iijima H, Shinzaki S, Nakajima S, Wang J, Kondo J, et al. Upregulation of GRAIL is associated with remission of ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 2008;295:G163–9.PubMedCrossRef Egawa S, Iijima H, Shinzaki S, Nakajima S, Wang J, Kondo J, et al. Upregulation of GRAIL is associated with remission of ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 2008;295:G163–9.PubMedCrossRef
16.
Zurück zum Zitat MacDonald TT, Monteleone I, Fantini MC, Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology. 2011;140:1768–75.PubMedCrossRef MacDonald TT, Monteleone I, Fantini MC, Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology. 2011;140:1768–75.PubMedCrossRef
17.
Zurück zum Zitat Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2–6; discussion 16–9. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2–6; discussion 16–9.
19.
Zurück zum Zitat Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–44.PubMed Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–44.PubMed
20.
Zurück zum Zitat Fujihashi K, Taguchi T, Aicher WK, McGhee JR, Bluestone JA, Eldridge JH, et al. Immunoregulatory functions for murine intraepithelial lymphocytes: gamma/delta T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while alpha/beta TCR+ T cells provide B cell help. J Exp Med. 1992;175:695–707.PubMedCrossRef Fujihashi K, Taguchi T, Aicher WK, McGhee JR, Bluestone JA, Eldridge JH, et al. Immunoregulatory functions for murine intraepithelial lymphocytes: gamma/delta T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while alpha/beta TCR+ T cells provide B cell help. J Exp Med. 1992;175:695–707.PubMedCrossRef
21.
Zurück zum Zitat Takahashi I, Kiyono H, Hamada S. CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology. 1997;112:1876–86.PubMedCrossRef Takahashi I, Kiyono H, Hamada S. CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology. 1997;112:1876–86.PubMedCrossRef
22.
Zurück zum Zitat Sudo H, Mizoguchi A, Kawauchi J, Akiyama H, Takizawa S. Use of non-amplified RNA samples for microarray analysis of gene expression. PLoS ONE. 2012;7:e31397.PubMedCentralPubMedCrossRef Sudo H, Mizoguchi A, Kawauchi J, Akiyama H, Takizawa S. Use of non-amplified RNA samples for microarray analysis of gene expression. PLoS ONE. 2012;7:e31397.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001;29:365–71.PubMedCrossRef Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001;29:365–71.PubMedCrossRef
24.
Zurück zum Zitat Dohi T, Ejima C, Kato R, Kawamura YI, Kawashima R, Mizutani N, et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology. 2005;128:411–23.PubMedCrossRef Dohi T, Ejima C, Kato R, Kawamura YI, Kawashima R, Mizutani N, et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology. 2005;128:411–23.PubMedCrossRef
25.
Zurück zum Zitat Soares L, Seroogy C, Skrenta H, Anandasabapathy N, Lovelace P, Chung CD, et al. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nat Immunol. 2004;5:45–54.PubMedCrossRef Soares L, Seroogy C, Skrenta H, Anandasabapathy N, Lovelace P, Chung CD, et al. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nat Immunol. 2004;5:45–54.PubMedCrossRef
26.
Zurück zum Zitat Sinkkonen L, Hugenschmidt T, Berninger P, Gaidatzis D, Mohn F, Artus-Revel CG, et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol. 2008;15:259–67.PubMedCrossRef Sinkkonen L, Hugenschmidt T, Berninger P, Gaidatzis D, Mohn F, Artus-Revel CG, et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol. 2008;15:259–67.PubMedCrossRef
28.
Zurück zum Zitat Sturm A, Leite AZ, Danese S, Krivacic KA, West GA, Mohr S, et al. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis. Gut. 2004;53:1624–31.PubMedCentralPubMedCrossRef Sturm A, Leite AZ, Danese S, Krivacic KA, West GA, Mohr S, et al. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis. Gut. 2004;53:1624–31.PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Lin JT, Lineberry NB, Kattah MG, Su LL, Utz PJ, Fathman CG, et al. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression. J Immunol. 2009;182:5919–28.PubMedCentralPubMedCrossRef Lin JT, Lineberry NB, Kattah MG, Su LL, Utz PJ, Fathman CG, et al. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression. J Immunol. 2009;182:5919–28.PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Dalal SR, Kwon JH. The role of MicroRNA in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6:714–22.PubMedCentral Dalal SR, Kwon JH. The role of MicroRNA in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6:714–22.PubMedCentral
Metadaten
Titel
Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn’s disease
verfasst von
Akira Mukai
Hideki Iijima
Satoshi Hiyama
Hironobu Fujii
Shinichiro Shinzaki
Takahiro Inoue
Eri Shiraishi
Shoichiro Kawai
Manabu Araki
Yoshito Hayashi
Jumpei Kondo
Tsunekazu Mizushima
Tatsuya Kanto
Satoshi Egawa
Tsutomu Nishida
Masahiko Tsujii
Tetsuo Takehara
Publikationsdatum
01.12.2014
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 12/2014
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-013-0923-x

Weitere Artikel der Ausgabe 12/2014

Journal of Gastroenterology 12/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.